ARUGA MEDICINES LTD
Opportunity 70/100 (strong), bankability 70/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (63/100).
Data confidence
Overall: high (83/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total assets | £100 | £100 |
| Current assets | £100 | £100 |
| Net assets | £100 | £100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
Corporate timeline (16 events)Click to expand
- 2025-09-08📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-09-10📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-04-17📄termination-director-company-with-name-termination-dateofficers · TM01
- 2024-04-17📄termination-director-company-with-name-termination-dateofficers · TM01
- 2024-04-16➖LAL, Rameshwer, Dr resigneddirector
- 2024-04-16➖REHMAN, Usman Habib, Dr resigneddirector
- 2024-04-09📄change-account-reference-date-company-previous-extendedaccounts · AA01
- 2023-07-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-10-04🏢Company incorporatedAs ARUGA MEDICINES LTD
- 2021-10-04➕ALI, Azhar, Dr. appointedsecretary
- 2021-10-04➕ALI, Azhar, Dr. appointeddirector
- 2021-10-04➕ALI, Gazenfer appointeddirector
- 2021-10-04➕RAMZAN, Arfan appointeddirector
- 2021-10-04➕LAL, Rameshwer, Dr appointeddirector
- 2021-10-04➕REHMAN, Usman Habib, Dr appointeddirector
- 2021-10-04📄incorporation-companyincorporation · NEWINC
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
Red flags
cleanGroup structure
Aruga Health Ltd. holds 25-50% — a significant corporate investor but not a controlling parent.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Aruga Health Ltd. Corporate entity | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 04/10/2021 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Retail · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A V I K PVT LTD→ SC808881 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| A WALK IN THE PARK LTD.→ SC386999 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| A&Z SOURCING LTD→ SC794948 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ASIAN1991 LTD→ SC585606 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| ATSAANG LIMITED→ SC814914 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AURA TAN LTD→ SC850707 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AXION TECHNOLOGY LIMITED→ SC777535 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AYOOLA SUPERMARKET LTD→ SC881881 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AZI FOODS LTD→ SC773321 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AZS786 LTD→ SC666530 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AZWAH LTD→ SC864545 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| B2B PHARMER LTD→ SC702024 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (4 active · 2 resigned)
Click a director name to see their full track record across all companies.